In the N2-3 category subgroup, concurrent chemotherapy seemed to provide an OS with a HR of 1.14 (95% CI: 0.81-1.60), however, this trend did not reach statistical significance ( P = 0.465).
← all excerpts
Matched analysis of induction chemotherapy plus chemoradiotherapy versus induction chemotherapy plus radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a multicenter study.
1
0.4650
0.4650